FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944210907> ?p ?o ?g. }

• W2944210907 abstract "Treatment switching is common in randomised trials of oncology treatments, with control group patients switching onto the experimental treatment during follow-up. This distorts an intention-to-treat comparison of the treatments under investigation. Two-stage estimation (TSE) can be used to estimate counterfactual survival times for patients who switch treatments – that is, survival times that would have been observed in the absence of switching. However, when switchers do not die during the study, counterfactual censoring times are estimated, inducing informative censoring. Re-censoring is usually applied alongside TSE to resolve this problem, but results in lost longer-term information – a major concern if the objective is to estimate long-term treatment effects, as is usually the case in health technology assessment. Inverse probability of censoring weights (IPCW) represents an alternative technique for addressing informative censoring but has not before been combined with TSE. We aim to determine whether combining TSE with IPCW (TSEipcw) represents a valid alternative to re-censoring. We conducted a simulation study to compare TSEipcw to TSE with and without re-censoring. We simulated 48 scenarios where control group patients could switch onto the experimental treatment, with switching affected by prognosis. We investigated various switching proportions, treatment effects, survival function shapes, disease severities and switcher prognoses. We assessed the alternative TSE applications according to their estimation of control group restricted mean survival (RMST) that would have been observed in the absence of switching up to the end of trial follow-up. TSEipcw performed well when its weights had a low coefficient of variation, but performed poorly when the coefficient of variation was high. Re-censored analyses usually under-estimated control group RMST, whereas non-re-censored analyses usually produced over-estimates, with bias more serious when the treatment effect was high. In scenarios where TSEipcw performed well, it produced low bias that was often between the two extremes associated with the re-censoring and non-recensoring options. Treatment switching adjustment analyses using TSE should be conducted with re-censoring, without re-censoring, and with IPCW to explore the sensitivity in results to these application options. This should allow analysts and decision-makers to better interpret the results of adjustment analyses." @default.
• W2944210907 created "2019-05-16" @default.
• W2944210907 creator A5004828576 @default.
• W2944210907 creator A5007269697 @default.
• W2944210907 creator A5012627256 @default.
• W2944210907 date "2019-03-29" @default.
• W2944210907 modified "2023-10-14" @default.
• W2944210907 title "Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring" @default.
• W2944210907 cites W1543389126 @default.
• W2944210907 cites W165253542 @default.
• W2944210907 cites W1963805911 @default.
• W2944210907 cites W1973794297 @default.
• W2944210907 cites W1982866065 @default.
• W2944210907 cites W1985489267 @default.
• W2944210907 cites W1988174589 @default.
• W2944210907 cites W1995452486 @default.
• W2944210907 cites W2003493540 @default.
• W2944210907 cites W2012761285 @default.
• W2944210907 cites W2017979374 @default.
• W2944210907 cites W2022946202 @default.
• W2944210907 cites W2026365806 @default.
• W2944210907 cites W2043549803 @default.
• W2944210907 cites W2047186977 @default.
• W2944210907 cites W2053337698 @default.
• W2944210907 cites W2062274192 @default.
• W2944210907 cites W2071066672 @default.
• W2944210907 cites W2080071258 @default.
• W2944210907 cites W2080076121 @default.
• W2944210907 cites W2090375377 @default.
• W2944210907 cites W2095967516 @default.
• W2944210907 cites W2100940220 @default.
• W2944210907 cites W2105592956 @default.
• W2944210907 cites W2122018306 @default.
• W2944210907 cites W2126499930 @default.
• W2944210907 cites W2131308548 @default.
• W2944210907 cites W2139276809 @default.
• W2944210907 cites W2140326213 @default.
• W2944210907 cites W2142495742 @default.
• W2944210907 cites W2145019571 @default.
• W2944210907 cites W2344464303 @default.
• W2944210907 cites W2385974944 @default.
• W2944210907 cites W2408822595 @default.
• W2944210907 cites W2519603001 @default.
• W2944210907 cites W2520063103 @default.
• W2944210907 cites W2598334350 @default.
• W2944210907 cites W2802389870 @default.
• W2944210907 cites W3098865414 @default.
• W2944210907 doi "https://doi.org/10.1186/s12874-019-0709-9" @default.
• W2944210907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6444622" @default.
• W2944210907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30935369" @default.
• W2944210907 hasPublicationYear "2019" @default.
• W2944210907 type Work @default.
• W2944210907 sameAs 2944210907 @default.
• W2944210907 citedByCount "11" @default.
• W2944210907 countsByYear W29442109072020 @default.
• W2944210907 countsByYear W29442109072021 @default.
• W2944210907 countsByYear W29442109072022 @default.
• W2944210907 countsByYear W29442109072023 @default.
• W2944210907 crossrefType "journal-article" @default.
• W2944210907 hasAuthorship W2944210907A5004828576 @default.
• W2944210907 hasAuthorship W2944210907A5007269697 @default.
• W2944210907 hasAuthorship W2944210907A5012627256 @default.
• W2944210907 hasBestOaLocation W29442109071 @default.
• W2944210907 hasConcept C105795698 @default.
• W2944210907 hasConcept C107673813 @default.
• W2944210907 hasConcept C126838900 @default.
• W2944210907 hasConcept C137668524 @default.
• W2944210907 hasConcept C146357865 @default.
• W2944210907 hasConcept C149782125 @default.
• W2944210907 hasConcept C151730666 @default.
• W2944210907 hasConcept C162324750 @default.
• W2944210907 hasConcept C183115368 @default.
• W2944210907 hasConcept C185429906 @default.
• W2944210907 hasConcept C187736073 @default.
• W2944210907 hasConcept C26831200 @default.
• W2944210907 hasConcept C2779915747 @default.
• W2944210907 hasConcept C33923547 @default.
• W2944210907 hasConcept C35981017 @default.
• W2944210907 hasConcept C41008148 @default.
• W2944210907 hasConcept C44249647 @default.
• W2944210907 hasConcept C57830394 @default.
• W2944210907 hasConcept C71924100 @default.
• W2944210907 hasConcept C86803240 @default.
• W2944210907 hasConcept C96250715 @default.
• W2944210907 hasConceptScore W2944210907C105795698 @default.
• W2944210907 hasConceptScore W2944210907C107673813 @default.
• W2944210907 hasConceptScore W2944210907C126838900 @default.
• W2944210907 hasConceptScore W2944210907C137668524 @default.
• W2944210907 hasConceptScore W2944210907C146357865 @default.
• W2944210907 hasConceptScore W2944210907C149782125 @default.
• W2944210907 hasConceptScore W2944210907C151730666 @default.
• W2944210907 hasConceptScore W2944210907C162324750 @default.
• W2944210907 hasConceptScore W2944210907C183115368 @default.
• W2944210907 hasConceptScore W2944210907C185429906 @default.
• W2944210907 hasConceptScore W2944210907C187736073 @default.
• W2944210907 hasConceptScore W2944210907C26831200 @default.
• W2944210907 hasConceptScore W2944210907C2779915747 @default.
• W2944210907 hasConceptScore W2944210907C33923547 @default.
• W2944210907 hasConceptScore W2944210907C35981017 @default.
• W2944210907 hasConceptScore W2944210907C41008148 @default.

• next